Standard and low-dose hormone therapy for postmenopausal women–focus on the breast
This review examines the effects of standard and low-dose hormone therapy (HT) on postmenopausal women, particularly in relation to breast health. HT remains the most effective treatment for menopausal symptoms, though prolonged use of estrogen-progestogen therapy (EPT) may slightly increase breast cancer risk, which diminishes after discontinuation. Low-dose HT provides
June 26, 2025
No Comments